ahlam1399
08-30-2016, 06:30 PM
UPDATE 1-Rigel?s bleeding disorder drug clears first of two key trials
Aug 30 (Reuters) - Rigel Pharmaceuticals Inc said its experimental drug to treat a bleeding disorder met its main goal in the first of two late-stage trials, sending its shares up 12 pct in... http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=dVqcVWUpEPg:qR27y7a1OjI:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=dVqcVWUpEPg:qR27y7a1OjI:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=dVqcVWUpEPg:qR27y7a1OjI:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=dVqcVWUpEPg:qR27y7a1OjI:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=dVqcVWUpEPg:qR27y7a1OjI:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/dVqcVWUpEPg
Aug 30 (Reuters) - Rigel Pharmaceuticals Inc said its experimental drug to treat a bleeding disorder met its main goal in the first of two late-stage trials, sending its shares up 12 pct in... http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=dVqcVWUpEPg:qR27y7a1OjI:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=dVqcVWUpEPg:qR27y7a1OjI:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=dVqcVWUpEPg:qR27y7a1OjI:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=dVqcVWUpEPg:qR27y7a1OjI:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=dVqcVWUpEPg:qR27y7a1OjI:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/dVqcVWUpEPg